Logo
R

RedShiftBio

30 employees

RedShift BioAnalytics is a developer and manufacturer of bioanalytical tools for the life science market.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CD-UV – Circular Dichroism Ultraviolet
Life Science
Formulation
Process Development
Tunable Infared Filters
Drug Discovery
UV BCA – Ultraviolet BiCinchoninic Acid assay
FT-IR
Enterprise Software
Product Design
Biosimilar
Stability
Manufacturing
HPLC-SEC - High Performance Liquid Chromatography-Size Exclusion Chromatography
Aggregation
Electronics
Biologics
Quantum Cascade Lasers
Antibodies
Molecular Spectroscopy
Biophysical Characterization
Biotherapeutics Analysis
Protein Characterization
Secondary Structure
DSC - Differential Scanning Calorimetry

Date founded

2005

Funding rounds raised

Total raised

$20M

from 4 investors over 4 rounds

R

RedShiftBio raised $20M on October 18, 2021

Investors: Illumina Ventures

R

RedShiftBio raised $12M on January 12, 2006

Investors: Alta Partners, InterWest Partners and Vesbridge Partners

FAQ